Publication:

JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective study

Date

Date

Date
2024
Journal Article
Published version

Citations

Citation copied

Fischer, M., Olbrich, P., Hadjadj, J., Aumann, V., Bakhtiar, S., Barlogis, V., von Bismarck, P., Bloomfield, M., Booth, C., Buddingh, E. P., Cagdas, D., Castelle, M., Chan, A. Y., Chandrakasan, S., Chetty, K., Cougoul, P., Crickx, E., Dara, J., Deyà-Martínez, A., … et al. (2024). JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective study. Journal of Allergy and Clinical Immunology, 153, 275-286.e18. https://doi.org/10.1016/j.jaci.2023.10.018

Abstract

Abstract

Abstract

Background: Inborn errors of immunity (IEI) with dysregulated JAK/STAT signaling present with variable manifestations of immune dysregulation and infections. Hematopoietic stem cell transplantation (HSCT) is potentially curative, but initially reported outcomes were poor. JAK inhibitors (JAKi) offer a targeted treatment option that may be an alternative or bridge to HSCT. However, data on their current use, treatment efficacy and adverse events are limited.

Objective: We evaluated the current off-label JAKi treatment experience for J

Metrics

Views

1 since deposited on 2024-01-30
Acq. date: 2025-11-12

Additional indexing

Creators (Authors)

  • Fischer, Marco
    affiliation.icon.alt
  • Olbrich, Peter
    affiliation.icon.alt
  • Hadjadj, Jérôme
    affiliation.icon.alt
  • Aumann, Volker
    affiliation.icon.alt
  • Bakhtiar, Shahrzad
    affiliation.icon.alt
  • Barlogis, Vincent
    affiliation.icon.alt
  • von Bismarck, Philipp
    affiliation.icon.alt
  • Bloomfield, Markéta
    affiliation.icon.alt
  • Booth, Claire
    affiliation.icon.alt
  • Buddingh, Emmeline P
    affiliation.icon.alt
  • Cagdas, Deniz
    affiliation.icon.alt
  • Castelle, Martin
    affiliation.icon.alt
  • Chan, Alice Y
    affiliation.icon.alt
  • Chandrakasan, Shanmuganathan
    affiliation.icon.alt
  • Chetty, Kritika
    affiliation.icon.alt
  • Cougoul, Pierre
    affiliation.icon.alt
  • Crickx, Etienne
    affiliation.icon.alt
  • Dara, Jasmeen
    affiliation.icon.alt
  • Deyà-Martínez, Angela
    affiliation.icon.alt
  • Farmand, Susan
    affiliation.icon.alt
  • Formankova, Renata
    affiliation.icon.alt
  • Gennery, Andrew R
    affiliation.icon.alt
  • Gonzalez-Granado, Luis Ignacio
    affiliation.icon.alt
  • Hagin, David
    affiliation.icon.alt
  • Hanitsch, Leif Gunnar
    affiliation.icon.alt
  • Hanzlikovà, Jana
    affiliation.icon.alt
  • Hauck, Fabian
    affiliation.icon.alt
  • Ivorra-Cortés, José
    affiliation.icon.alt
  • Kisand, Kai
    affiliation.icon.alt
  • Kiykim, Ayca
    affiliation.icon.alt
  • et al

Journal/Series Title

Journal/Series Title

Journal/Series Title

Volume

Volume

Volume
153

Number

Number

Number
1

Page range/Item number

Page range/Item number

Page range/Item number
275

Page end

Page end

Page end
286.e18

Item Type

Item Type

Item Type
Journal Article

Dewey Decimal Classifikation

Dewey Decimal Classifikation

Dewey Decimal Classifikation

Keywords

Immunology, Immunology and Allergy; JAK inhibitor; JAK/STAT signaling; autoimmunity; baricitinib; chronic mucocutaneous candidiasis; gain of function; immune dysregulation; inborn error of immunity; primary immunodeficiency; ruxolitinib

Language

Language

Language
English

Publication date

Publication date

Publication date
2024-01-01

Date available

Date available

Date available
2024-01-30

Publisher

Publisher

Publisher

ISSN or e-ISSN

ISSN or e-ISSN

ISSN or e-ISSN
0091-6749

OA Status

OA Status

OA Status
Closed

Free Access at

Free Access at

Free Access at
Unspecified

PubMed ID

PubMed ID

PubMed ID

Metrics

Views

1 since deposited on 2024-01-30
Acq. date: 2025-11-12

Citations

Citation copied

Fischer, M., Olbrich, P., Hadjadj, J., Aumann, V., Bakhtiar, S., Barlogis, V., von Bismarck, P., Bloomfield, M., Booth, C., Buddingh, E. P., Cagdas, D., Castelle, M., Chan, A. Y., Chandrakasan, S., Chetty, K., Cougoul, P., Crickx, E., Dara, J., Deyà-Martínez, A., … et al. (2024). JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective study. Journal of Allergy and Clinical Immunology, 153, 275-286.e18. https://doi.org/10.1016/j.jaci.2023.10.018

Closed
Loading...
Thumbnail Image

Files

Files

Files
Files available to download:1

Files

Files

Files
Files available to download:1
Loading...
Thumbnail Image